RGI 3600
Alternative Names: RGI-3600Latest Information Update: 11 Sep 2023
Price :
$50 *
At a glance
- Originator REGiMMUNE
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammatory bowel diseases
Most Recent Events
- 11 Sep 2023 Discontinued - Preclinical for Inflammatory bowel diseases in Japan (unspecified route) (REGiMMUNE pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in Japan
- 20 Jul 2016 Preclinical trials in Inflammatory bowel disease in Japan (unspecified route) before July 2016